Earlier this month, Regimbeau had the privilege of participating in one of the very first hearings on the merits before the UPC’s Court of Appeal in Luxembourg (4–5 September), where we represented Meril Italy in its action for revocation of a first European patent held by Edwards Lifesciences.
Only a week later, the same team appeared again before the UPC Central Division in Paris, this time representing several companies of the Meril group in litigation concerning the validity and alleged infringement of a second European patent, also held by Edwards Lifesciences.
Team:
- Before the Court of Appeal (Luxembourg): Anne Seibel, Aurélien Grimberg, Julien Guesnier (Regimbeau), Emmanuel Larere, Raphaëlle Dequiré-Portier, Luca Chevallier, Ludivine Messirel, Carole-Anne Bauer (Gide), Andreas von Falck and Alexander Klicznik (Hogan Lovells), and Jonathan Stafford and Gregory Carty-Hornsby (Marks & Clerk).
- Before the Central Division (Paris): Anne Seibel, Aurélien Grimberg, Julien Guesnier (Regimbeau), Jean-Hyacinthe de Mitry, Emmanuel Larere, Marie-Ange Pozzo di Borgo, Célia Révy, Emmanuel Baux-Hendrix (Gide), and Jonathan Stafford and Gregory Carty-Hornsby (Marks & Clerk).
Regimbeau extends its sincere thanks to Nilay Lad, Head of Patents and Innovation at the Meril Group, for his trust and confidence.
